{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,26]],"date-time":"2026-03-26T11:40:07Z","timestamp":1774525207411,"version":"3.50.1"},"reference-count":37,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2016,9,21]],"date-time":"2016-09-21T00:00:00Z","timestamp":1474416000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2016,9,21]],"date-time":"2016-09-21T00:00:00Z","timestamp":1474416000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["npj Genomic Med"],"abstract":"<jats:title>Abstract<\/jats:title><jats:p>The Ontario Neurodegenerative Disease Research Initiative (ONDRI) is a multimodal, multi-year, prospective observational cohort study to characterise five diseases: (1) Alzheimer\u2019s disease (AD) or amnestic single or multidomain mild cognitive impairment (aMCI) (AD\/MCI); (2) amyotrophic lateral sclerosis (ALS); (3) frontotemporal dementia (FTD); (4) Parkinson\u2019s disease (PD); and (5) vascular cognitive impairment (VCI). The ONDRI Genomics subgroup is investigating the genetic basis of neurodegeneration. We have developed a custom next-generation-sequencing-based panel, ONDRISeq that targets 80 genes known to be associated with neurodegeneration. We processed DNA collected from 216 individuals diagnosed with one of the five diseases, on ONDRISeq. All runs were executed on a MiSeq instrument and subjected to rigorous quality control assessments. We also independently validated a subset of the variant calls using NeuroX (a genome-wide array for neurodegenerative disorders), TaqMan allelic discrimination assay, or Sanger sequencing. ONDRISeq consistently generated high-quality genotyping calls and on average, 92% of targeted bases are covered by at least 30 reads. We also observed 100% concordance for the variants identified via ONDRISeq and validated by other genomic technologies. We were successful in detecting known as well as novel rare variants in 72.2% of cases although not all variants are disease-causing. Using ONDRISeq, we also found that the <jats:italic>APOE<\/jats:italic> E4 allele had a frequency of 0.167 in these samples. Our optimised workflow highlights next-generation sequencing as a robust tool in elucidating the genetic basis of neurodegenerative diseases by screening multiple candidate genes simultaneously.<\/jats:p>","DOI":"10.1038\/npjgenmed.2016.32","type":"journal-article","created":{"date-parts":[[2016,9,21]],"date-time":"2016-09-21T13:08:59Z","timestamp":1474463339000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":26,"title":["The ONDRISeq panel: custom-designed next-generation sequencing of genes related to neurodegeneration"],"prefix":"10.1038","volume":"1","author":[{"given":"Sali M K","family":"Farhan","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Allison A","family":"Dilliott","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mahdi","family":"Ghani","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Christine","family":"Sato","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Eric","family":"Liang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ming","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Adam D","family":"McIntyre","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Henian","family":"Cao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lemuel","family":"Racacho","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"John F","family":"Robinson","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Michael J","family":"Strong","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mario","family":"Masellis","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Peter","family":"St George-Hyslop","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dennis E","family":"Bulman","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ekaterina","family":"Rogaeva","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2861-5325","authenticated-orcid":false,"given":"Robert A","family":"Hegele","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"name":"ONDRI Investigators","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2016,9,21]]},"reference":[{"key":"BFnpjgenmed201632_CR1","unstructured":"World Alzheimer Report 2013. Journey of Caring. an Analysis of Long-Term Care for Dementia: Available at https:\/\/www.alz.co.uk\/research\/WorldAlzheimerReport2013.pdf. Accessed 26 August 2015."},{"key":"BFnpjgenmed201632_CR2","doi-asserted-by":"crossref","unstructured":"WHO takes up the baton on dementia. Lancet Neurol. 14, 455 (2015).","DOI":"10.1016\/S1474-4422(15)00022-8"},{"key":"BFnpjgenmed201632_CR3","doi-asserted-by":"publisher","first-page":"h3029","DOI":"10.1136\/bmj.h3029","volume":"350","author":"L Robinson","year":"2015","unstructured":"Robinson, L., Tang, E. & Taylor, J. P. Dementia: timely diagnosis and early intervention. BMJ 350, h3029 (2015).","journal-title":"BMJ"},{"key":"BFnpjgenmed201632_CR4","doi-asserted-by":"publisher","first-page":"1778","DOI":"10.1212\/WNL.0b013e31828726f5","volume":"80","author":"LE Hebert","year":"2013","unstructured":"Hebert, L. E., Weuve, J., Scherr, P. A. & Evans, D. A. Alzheimer disease in the United States (2010-2050) estimated using the 2010 census. Neurology 80, 1778\u20131783 (2013).","journal-title":"Neurology"},{"key":"BFnpjgenmed201632_CR5","doi-asserted-by":"publisher","first-page":"R47","DOI":"10.1093\/hmg\/ddu203","volume":"23","author":"R Guerreiro","year":"2014","unstructured":"Guerreiro, R., Bras, J., Hardy, J. & Singleton, A. Next generation sequencing techniques in neurological diseases: redefining clinical and molecular associations. Hum. Mol. Genet. 23, R47\u2013R53 (2014).","journal-title":"Hum. Mol. Genet."},{"key":"BFnpjgenmed201632_CR6","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1038\/nn.3584","volume":"17","author":"AE Renton","year":"2014","unstructured":"Renton, A. E., Chio, A. & Traynor, B. J. State of play in amyotrophic lateral sclerosis genetics. Nat. Neurosci. 17, 17\u201323 (2014).","journal-title":"Nat. Neurosci."},{"key":"BFnpjgenmed201632_CR7","doi-asserted-by":"publisher","first-page":"291","DOI":"10.1016\/S1474-4422(14)70233-9","volume":"14","author":"JD Rohrer","year":"2015","unstructured":"Rohrer, J. D. et al. C9orf72 expansions in frontotemporal dementia and amyotrophic lateral sclerosis. Lancet Neurol. 14, 291\u2013301 (2015).","journal-title":"Lancet Neurol."},{"key":"BFnpjgenmed201632_CR8","doi-asserted-by":"publisher","first-page":"1227","DOI":"10.1212\/WNL.0b013e3181bc01a4","volume":"73","author":"RG Miller","year":"2009","unstructured":"Miller, R. G. et al. Practice parameter update: the care of the patient with amyotrophic lateral sclerosis: multidisciplinary care, symptom management, and cognitive\/behavioral impairment (an evidence-based review): report of the Quality Standards Subcommittee of the American Academy of Neurology. Neurology 73, 1227\u20131233 (2009).","journal-title":"Neurology"},{"key":"BFnpjgenmed201632_CR9","doi-asserted-by":"publisher","first-page":"1218","DOI":"10.1212\/WNL.0b013e3181bc0141","volume":"73","author":"RG Miller","year":"2009","unstructured":"Miller, R. G. et al. Practice parameter update: the care of the patient with amyotrophic lateral sclerosis: drug, nutritional, and respiratory therapies (an evidence-based review): report of the Quality Standards Subcommittee of the American Academy of Neurology. Neurology 73, 1218\u20131226 (2009).","journal-title":"Neurology"},{"key":"BFnpjgenmed201632_CR10","doi-asserted-by":"publisher","first-page":"S1","DOI":"10.1017\/S031716710001516X","volume":"39","author":"D Grimes","year":"2012","unstructured":"Grimes, D. et al. Canadian guidelines on Parkinson's disease. Can. J. Neurol. Sci. 39, S1\u201330 (2012).","journal-title":"Can. J. Neurol. Sci."},{"key":"BFnpjgenmed201632_CR11","doi-asserted-by":"publisher","first-page":"597","DOI":"10.1097\/GIM.0b013e31821d69b8","volume":"13","author":"JS Goldman","year":"2011","unstructured":"Goldman, J. S. et al. Genetic counseling and testing for Alzheimer disease: joint practice guidelines of the American College of Medical Genetics and the National Society of Genetic Counselors. Genet. Med. 13, 597\u2013605 (2011).","journal-title":"Genet. Med."},{"key":"BFnpjgenmed201632_CR12","doi-asserted-by":"publisher","first-page":"131","DOI":"10.1080\/17482960802654364","volume":"10","author":"MJ Strong","year":"2009","unstructured":"Strong, M. J. et al. Consensus criteria for the diagnosis of frontotemporal cognitive and behavioural syndromes in amyotrophic lateral sclerosis. Amyotroph Lateral Scler. 10, 131\u2013146 (2009).","journal-title":"Amyotroph Lateral Scler."},{"key":"BFnpjgenmed201632_CR13","doi-asserted-by":"publisher","first-page":"257","DOI":"10.1016\/j.jalz.2011.03.004","volume":"7","author":"CR Jack Jr","year":"2011","unstructured":"Jack, C. R. Jr et al. Introduction to the recommendations from the National Institute on Aging-Alzheimer's Association workgroups on diagnostic guidelines for Alzheimer's disease. Alzheimers Dement. 7, 257\u2013262 (2011).","journal-title":"Alzheimers Dement."},{"key":"BFnpjgenmed201632_CR14","doi-asserted-by":"publisher","first-page":"507","DOI":"10.1007\/s11886-014-0507-2","volume":"16","author":"SM Farhan","year":"2014","unstructured":"Farhan, S. M. & Hegele, R. A. Exome sequencing: new insights into lipoprotein disorders. Curr. Cardiol. Rep. 16, 507 (2014).","journal-title":"Curr. Cardiol. Rep."},{"key":"BFnpjgenmed201632_CR15","doi-asserted-by":"publisher","first-page":"565","DOI":"10.1038\/gim.2013.73","volume":"15","author":"RC Green","year":"2013","unstructured":"Green, R. C. et al. ACMG recommendations for reporting of incidental findings in clinical exome and genome sequencing. Genet. Med. 15, 565\u2013574 (2013).","journal-title":"Genet. Med."},{"key":"BFnpjgenmed201632_CR16","doi-asserted-by":"publisher","first-page":"145","DOI":"10.3233\/JAD-121069","volume":"34","author":"R Dwyer","year":"2013","unstructured":"Dwyer, R., Skrobot, O. A., Dwyer, J., Munafo, M. & Kehoe, P. G. Using Alzgene-like approaches to investigate susceptibility genes for vascular cognitive impairment. J. Alzheimers Dis. 34, 145\u2013154 (2013).","journal-title":"J. Alzheimers Dis."},{"key":"BFnpjgenmed201632_CR17","doi-asserted-by":"publisher","first-page":"611","DOI":"10.3233\/JAD-143102","volume":"46","author":"JH Sun","year":"2015","unstructured":"Sun, J. H. et al. Genetics of vascular dementia: systematic review and meta-analysis. J. Alzheimers Dis. 46, 611\u2013629 (2015).","journal-title":"J. Alzheimers Dis."},{"key":"BFnpjgenmed201632_CR18","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1038\/ng1934","volume":"39","author":"L Bertram","year":"2007","unstructured":"Bertram, L., McQueen, M. B., Mullin, K., Blacker, D. & Tanzi, R. E. Systematic meta-analyses of Alzheimer disease genetic association studies: the AlzGene database. Nat. Genet. 39, 17\u201323 (2007).","journal-title":"Nat. Genet."},{"key":"BFnpjgenmed201632_CR19","doi-asserted-by":"publisher","first-page":"910","DOI":"10.1212\/01.WNL.0000137048.80666.86","volume":"63","author":"G Rossi","year":"2004","unstructured":"Rossi, G. et al. A family with Alzheimer disease and strokes associated with A713T mutation of the APP gene. Neurology 63, 910\u2013912 (2004).","journal-title":"Neurology"},{"key":"BFnpjgenmed201632_CR20","doi-asserted-by":"publisher","first-page":"241","DOI":"10.1016\/j.neulet.2004.08.026","volume":"370","author":"J Armstrong","year":"2004","unstructured":"Armstrong, J., Boada, M., Rey, M. J., Vidal, N. & Ferrer, I. Familial Alzheimer disease associated with A713T mutation in APP. Neurosci. Lett. 370, 241\u2013243 (2004).","journal-title":"Neurosci. Lett."},{"key":"BFnpjgenmed201632_CR21","doi-asserted-by":"publisher","first-page":"383","DOI":"10.3233\/JAD-2009-1061","volume":"17","author":"L Bernardi","year":"2009","unstructured":"Bernardi, L. et al. AbetaPP A713T mutation in late onset Alzheimer's disease with cerebrovascular lesions. J. Alzheimers Dis. 17, 383\u2013389 (2009).","journal-title":"J. Alzheimers Dis."},{"key":"BFnpjgenmed201632_CR22","doi-asserted-by":"publisher","first-page":"545.e9","DOI":"10.1016\/j.neurobiolaging.2014.07.038","volume":"36","author":"M Ghani","year":"2015","unstructured":"Ghani, M. et al. Mutation analysis of patients with neurodegenerative disorders using NeuroX array. Neurobiol. Aging 36, 545.e9\u2013e14 (2015).","journal-title":"Neurobiol. Aging"},{"key":"BFnpjgenmed201632_CR23","doi-asserted-by":"publisher","first-page":"942","DOI":"10.1016\/S1474-4422(11)70196-X","volume":"10","author":"AB Singleton","year":"2011","unstructured":"Singleton, A. B. Exome sequencing: a transformative technology. Lancet Neurol. 10, 942\u2013946 (2011).","journal-title":"Lancet Neurol."},{"key":"BFnpjgenmed201632_CR24","doi-asserted-by":"publisher","first-page":"814","DOI":"10.1002\/ana.410360604","volume":"36","author":"AR La Spada","year":"1994","unstructured":"La Spada, A. R., Paulson, H. L. & Fischbeck, K. H. Trinucleotide repeat expansion in neurological disease. Ann. Neurol. 36, 814\u2013822 (1994).","journal-title":"Ann. Neurol."},{"key":"BFnpjgenmed201632_CR25","doi-asserted-by":"publisher","first-page":"565","DOI":"10.1038\/cr.2013.12","volume":"23","author":"JR Stevens","year":"2013","unstructured":"Stevens, J. R., Lahue, E. E., Li, G. M. & Lahue, R. S. Trinucleotide repeat expansions catalyzed by human cell-free extracts. Cell Res. 23, 565\u2013572 (2013).","journal-title":"Cell Res."},{"key":"BFnpjgenmed201632_CR26","doi-asserted-by":"publisher","first-page":"245","DOI":"10.1016\/j.neuron.2011.09.011","volume":"72","author":"M DeJesus-Hernandez","year":"2011","unstructured":"DeJesus-Hernandez, M. et al. Expanded GGGGCC hexanucleotide repeat in noncoding region of C9ORF72 causes chromosome 9p-linked FTD and ALS. Neuron 72, 245\u2013256 (2011).","journal-title":"Neuron"},{"key":"BFnpjgenmed201632_CR27","doi-asserted-by":"publisher","first-page":"257","DOI":"10.1016\/j.neuron.2011.09.010","volume":"72","author":"AE Renton","year":"2011","unstructured":"Renton, A. E. et al. A hexanucleotide repeat expansion in C9ORF72 is the cause of chromosome 9p21-linked ALS-FTD. Neuron 72, 257\u2013268 (2011).","journal-title":"Neuron"},{"key":"BFnpjgenmed201632_CR28","doi-asserted-by":"publisher","first-page":"1583","DOI":"10.1001\/archneurol.2012.2016","volume":"69","author":"Z Xi","year":"2012","unstructured":"Xi, Z. et al. Investigation of c9orf72 in 4 neurodegenerative disorders. Arch. Neurol. 69, 1583\u20131590 (2012).","journal-title":"Arch. Neurol."},{"key":"BFnpjgenmed201632_CR29","doi-asserted-by":"publisher","first-page":"962","DOI":"10.1016\/j.ajhg.2015.04.016","volume":"96","author":"Z Xi","year":"2015","unstructured":"Xi, Z. et al. Jump from pre-mutation to pathologic expansion in C9orf72. Am. J. Hum. Genet. 96, 962\u2013970 (2015).","journal-title":"Am. J. Hum. Genet."},{"key":"BFnpjgenmed201632_CR30","doi-asserted-by":"publisher","first-page":"986","DOI":"10.1016\/S1474-4422(12)70190-4","volume":"11","author":"E Sidransky","year":"2012","unstructured":"Sidransky, E. & Lopez, G. The link between the GBA gene and parkinsonism. Lancet Neurol. 11, 986\u2013998 (2012).","journal-title":"Lancet Neurol."},{"key":"BFnpjgenmed201632_CR31","unstructured":"Farhan, S. M. K. et al. The Ontario Neurodegenerative Disease Research Initiative (ONDRI). Can. J. Neurol. Sci (in the press)."},{"key":"BFnpjgenmed201632_CR32","doi-asserted-by":"publisher","first-page":"765","DOI":"10.1194\/jlr.D045963","volume":"55","author":"CT Johansen","year":"2014","unstructured":"Johansen, C. T. et al. LipidSeq: a next-generation clinical resequencing panel for monogenic dyslipidemias. J. Lipid Res. 55, 765\u2013772 (2014).","journal-title":"J. Lipid Res."},{"key":"BFnpjgenmed201632_CR33","doi-asserted-by":"publisher","first-page":"310","DOI":"10.1038\/ng.2892","volume":"46","author":"M Kircher","year":"2014","unstructured":"Kircher, M. et al. A general framework for estimating the relative pathogenicity of human genetic variants. Nat. Genet. 46, 310\u2013315 (2014).","journal-title":"Nat. Genet."},{"key":"BFnpjgenmed201632_CR34","doi-asserted-by":"publisher","first-page":"D980","DOI":"10.1093\/nar\/gkt1113","volume":"42","author":"MJ Landrum","year":"2014","unstructured":"Landrum, M. J. et al. ClinVar: public archive of relationships among sequence variation and human phenotype. Nucleic Acids Res. 42, D980\u2013D985 (2014).","journal-title":"Nucleic Acids Res."},{"key":"BFnpjgenmed201632_CR35","doi-asserted-by":"publisher","first-page":"285","DOI":"10.1038\/nature19057","volume":"536","author":"M Lek","year":"2016","unstructured":"Lek, M. et al. Analysis of protein-coding genetic variation in 60,706 humans. Nature 536, 285\u2013291 (2016).","journal-title":"Nature"},{"key":"BFnpjgenmed201632_CR36","doi-asserted-by":"publisher","first-page":"e149","DOI":"10.1093\/nar\/gni155","volume":"33","author":"N Ghebranious","year":"2005","unstructured":"Ghebranious, N., Ivacic, L., Mallum, J. & Dokken, C. Detection of ApoE E2, E3 and E4 alleles using MALDI-TOF mass spectrometry and the homogeneous mass-extend technology. Nucleic Acids Res. 33, e149 (2005).","journal-title":"Nucleic Acids Res."},{"key":"BFnpjgenmed201632_CR37","doi-asserted-by":"publisher","first-page":"405","DOI":"10.1038\/gim.2015.30","volume":"17","author":"S Richards","year":"2015","unstructured":"Richards, S. et al. Standards and guidelines for the interpretation of sequence variants: a joint consensus recommendation of the American College of Medical Genetics and Genomics and the Association for Molecular Pathology. Genet. Med. 17, 405\u2013424 (2015).","journal-title":"Genet. Med."}],"container-title":["npj Genomic Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/npjgenmed201632.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/npjgenmed201632","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/npjgenmed201632.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,1,4]],"date-time":"2023-01-04T12:25:52Z","timestamp":1672835152000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/npjgenmed201632"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,9,21]]},"references-count":37,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2016,11,30]]}},"alternative-id":["BFnpjgenmed201632"],"URL":"https:\/\/doi.org\/10.1038\/npjgenmed.2016.32","relation":{},"ISSN":["2056-7944"],"issn-type":[{"value":"2056-7944","type":"electronic"}],"subject":[],"published":{"date-parts":[[2016,9,21]]},"assertion":[{"value":"9 March 2016","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"1 August 2016","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"5 August 2016","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"21 September 2016","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no conflict of interest.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"16032"}}